SMITH MARK L 4
4 · NABI BIOPHARMACEUTICALS · Filed Dec 20, 2004
Insider Transaction Report
Form 4
SMITH MARK L
Sr. VP Fin., CFO, CAO & Treas.
Transactions
- Other
Common Stock
2004-11-30$12.30/sh+1,056.911$13,000→ 18,679.79 total
Footnotes (1)
- [F1]Voluntarily reported acquisition under the issuer's 2000 Employee Stock Purchase Plan, which is an exempt transaction pursuant to Rule 16b-3(c).